Onyx Biotec Limited

Company Profile
Company Name Onyx Biotec Limited
Open Date 13-11-2024
Close Date 18-11-2024
Exchange NSE SME
Lot Size 2,000 Shares
Issue Price ₹58 to ₹61 per share
Issue Size 48,10,000 shares
Application Amount ₹1,22,000
Recommendation Avoid
Onyx Biotec Limited was originally incorporated on May 13, 2005. The registered office is located at Himachal Pradesh, India. The company is engaged in the manufacturing of range of Sterile Water for Injections, Dry Powder Injections and Dry Syrup. The company derives majority of its revenue from sterile water for injections. The company has 175 full-time employees as on Sep 30, 2024.
(Read more on the review)

Financial Summary in Lakhs

For the Period Ended Mar-22 Mar-23 Mar-24
Revenue 4,486.14 3,948.19 5,374.88
EBITDA 563.85 445.80 828.22
Net Profit 335.31 183.47 303.17
RoCE 15.63% 7.70% 11.71%
ROE 20.48% 10.08% 12.19%
P/E 21.48 39.10 24.02

Tentative Timeline

Opening Date 13-11-2024
Closing Date 18-11-2024
Basis of Allotment 19-11-2024
Initiation of Refunds 20-11-2024
Credit of Shares to Demat 20-11-2024
Listing Date 21-11-2024

Objects of the Issue

Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use
Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections
Prepayment or repayment of all or a portion of certain loans availed by the Company
General Corporate Purposes

Contact Information

Registered Office Onyx Biotec Limited Bir Plassi Near Sainimajraropar, Nalagarh Road District Solan – 174101
Phone +91 172 265 6384
Email generalinfo@onyxbiotec.com
Website http://www.onyxbiotec.com/

Registrar Details

Name Mas Services Limited
Phone (011) 2610 4142
Email ipo@masserv.com
Website https://www.masserv.com/opt.asp

IPO Reservation

QIB Shares Offered Not more than 49.89% of the Net Issue
Retail Shares Offered Not less than 35.04% of the Net Issue
NII (HNI) Shares Offered Not less than 15.07% of the Net Issue

Shareholding Pattern

Shareholding Pre Issue (Promoters) 88.60%
Shareholding Post Issue (Promoters) 65.10%

Contact Us to Enable Your Success!